Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations:
Anthropometry:
Systematic manoeuvres:
Systematic examination:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (tall stature / overgrowth / family concern). On examination, the child appears _____ (well/unwell/lethargic), with _____ (body habitus / dysmorphic features). Measurements: height _____ percentile, US:LS ratio _____, arm span _____ cm, head circumference _____ percentile. Manoeuvres: arachnodactyly _____ (present/absent), hypermobility _____. General exam: _____ (hands, face, chest, CVS, abdomen, genitalia). Developmental: _____ (delayed/appropriate). Associated signs: _____.
• Constitutional (familial) tall stature – normal variant
• Marfan syndrome – arachnodactyly, lens dislocation, aortic root dilation
• Homocystinuria – Marfanoid habitus + intellectual disability + thromboembolism
• Sotos syndrome – macrocephaly, learning disability, distinctive facies
• Beckwith‑Wiedemann syndrome – macrosomia, macroglossia, omphalocele, tumour risk
• Klinefelter syndrome – tall, thin, gynecomastia, small testes, learning difficulties
• XYY syndrome – tall, behavioural problems, severe acne
• Pituitary gigantism – excessive GH, large hands/feet, coarsening facies
• McCune‑Albright syndrome – fibrous dysplasia, café‑au‑lait spots, precocious puberty
• Hyperthyroidism – tremor, tachycardia, goitre
• Obesity (exogenous) – tall in childhood, but normal adult height
• Bone age – advanced (pituitary gigantism, precocious puberty), normal (constitutional, Marfan).
• GH / IGF‑1 – elevated (pituitary gigantism).
• Thyroid function – hyperthyroidism.
• Echocardiography – aortic root diameter (Marfan).
• Skeletal survey – fibrous dysplasia (McCune‑Albright), scoliosis.
• Genetic: FISH for 7q11.23 (Williams), FBN1 (Marfan), NSD1 (Sotos), karyotype (Klinefelter, XYY).
• Metabolic: plasma homocysteine (homocystinuria).
• Endocrine: IGF‑1, GH suppression test (gigantism).
• Echocardiography – exclude aortic dilation / dissection (Marfan).
• Ophthalmology – lens dislocation (Marfan, homocystinuria).
• Abdominal ultrasound – Wilms tumour (Beckwith‑Wiedemann).
• Echocardiography – aortic regurgitation, mitral valve prolapse (Marfan).
• CT/MRI brain – pituitary adenoma (gigantism).
• ABG – if metabolic acidosis (homocystinuria – rarely).
• Tumour markers – AFP (hepatoblastoma in Beckwith‑Wiedemann).
🔹 Management – Across Organ Systems
GH suppression (octreotide/pegvisomant) for gigantism; thyroid replacement if hypothyroid.
β‑blockers (Marfan – aortic root dilation); regular echocardiographic surveillance.
Lens extraction (Marfan/homocystinuria); regular eye exams.
Physiotherapy, orthopaedic referral (scoliosis, pectus).
Seizure management (Sotos, Beckwith‑Wiedemann).
Early intervention, educational support, speech therapy.
Abdominal US and AFP (Beckwith‑Wiedemann – Wilms, hepatoblastoma).
Recurrence risk (autosomal dominant, X‑linked, or de novo).
📈 Prognosis
📋 Follow‑up Schedule